A database of publications about African genetic resources and digital sequence information — real bibliographic metadata pulled from PubMed, with a durable link back to the source record. Papers that aren't on PubMed, given by curators as evidence, are listed beside them from Crossref, linked by their DOI to the publisher. Full text is frequently paywalled even when the abstract/metadata is open, so this is a metadata catalog with an outbound link, not a hosted archive; this platform never claims to host or redistribute full text.
Whole genome sequencing-based detection of antimicrobial resistance and virulence in non-typhoidal Salmonella enterica isolated from wildlife.
Thomas M, Fenske GJ, Antony L, Ghimire S, Welsh R, Ramachandran A, Scaria J · Gut Pathog (2017)
· DOI: 10.1186/s13099-017-0213-x
The aim of this study was to generate a reference set of Salmonella enterica genomes isolated from wildlife from the United States and to determine the antimicrobial resistance and virulence gene profile of the isolates from the genome sequence data. We sequenced the whole genomes of 103 Salmonella isolates sampled between 1988 and 2003 from wildlife and exotic pet cases that were submitted to the Oklahoma Animal Disease Diagnostic Laboratory, Stillwater, Oklahoma. Among 103 isolates, 50.48% were from wild birds, 0.9% was from fish, 24.27% each were from reptiles and mammals. 50.48% isolates showed resistance to at least one antibiotic. Resistance against the aminoglycoside streptomycin was most common while 9 isolates were found to be multi-drug resistant having resistance against more than three antibiotics. Determination of virulence gene profile revealed that the genes belonging to csg operons, the fim genes that encode for type 1 fimbriae and the genes belonging to type III secretion system were predominant among the isolates. The universal presence of fimbrial genes and the genes encoded by pathogenicity islands 1-2 among the isolates we report here indicates that these isolates could potentially cause disease in humans. Therefore, the genomes we report here could be a valuable reference point for future traceback investigations when wildlife is considered to be the potential source of human Salmonellosis.
Feed withdrawal and transport commonly occur together in pigs. Objectives of this study were to determine if these preslaughter stressors, feed withdrawal and transportation, affect the levels of , stress hormone concentrations, and immune functions in infected market pigs. A 2 × 2 factorial analysis of a randomized complete block design with feed withdrawal and transport as fixed effects was used. Sixty market-weight pigs were individually inoculated with serovar Typhimurium. The experiment was replicated 3 times (blocking factor) with 20 pigs per replicate. Three days after inoculation, the pigs were randomly assigned to 1 of 4 treatments (5 pigs per treatment in each/replicate), including 1) control (Control; or no stress), 2) feed withdrawal for 12 h (FW), 3) transportation for 2 h (T), and 4) feed withdrawal for 12 h followed by transportation for 2 h (FWT). Feed withdrawal by itself or followed by transportation caused an increase of levels in ileal contents ( < 0.05), whereas only FWT caused an increase of levels in cecal contents ( < 0.05). Rectal contents (feces) consistently contained very low levels of , with no difference among treatments ( > 0.10). Cortisol increased in pigs from all 3 stress treatments ( < 0.001), with T and FWT pigs having greater concentrations than Control pigs ( < 0.05), although total white blood cell counts were lower for FWT pigs compared with Controls ( > 0.03). Each granulocyte percentage (neutrophil, eosinophils, and basophils) increased ( < 0.05) following transport but was attenuated ( > 0.05) by feed withdrawal with transport. Lymphocytes were suppressed ( < 0.05) by all stressors, and the greatest suppression occurred when pigs were transported (T and FWT). However, monocytes were suppressed ( < 0.05) compared with Controls only by FWT. Expression of IL-1 (produced by monocytes/macrophages) from the spleen cells increased ( < 0.05) with FW compared with Controls, whereas its receptor antagonist was suppressed by FWT ( < 0.05). It is concluded that some typical preslaughter practices, such as feed withdrawal and transportation, lead to greater intestinal levels and gut-associated lymphoid tissue markers of inflammation in market pigs and, consequently, to an increased food safety risk.
The Ever-Expanding Pseudomonas Genus: Description of 43 New Species and Partition of the Pseudomonas putida Group.
Girard L, Lood C, Höfte M, Vandamme P, Rokni-Zadeh H, van Noort V, Lavigne R, De Mot R · Microorganisms (2021)
· DOI: 10.3390/microorganisms9081766
The genus Pseudomonas hosts an extensive genetic diversity and is one of the largest genera among Gram-negative bacteria. Type strains of Pseudomonas are well known to represent only a small fraction of this diversity and the number of available Pseudomonas genome sequences is increasing rapidly. Consequently, new Pseudomonas species are regularly reported and the number of species within the genus is constantly evolving. In this study, whole genome sequencing enabled us to define 43 new Pseudomonas species and provide an update of the Pseudomonas evolutionary and taxonomic relationships. Phylogenies based on the rpoD gene and whole genome sequences, including, respectively, 316 and 313 type strains of Pseudomonas, revealed sixteen groups of Pseudomonas and, together with the distribution of cyclic lipopeptide biosynthesis gene clusters, enabled the partitioning of the P. putida group into fifteen subgroups. Pairwise average nucleotide identities were calculated between type strains and a selection of 60 genomes of non-type strains of Pseudomonas. Forty-one strains were incorrectly assigned at the species level and among these, 19 strains were shown to represent an additional 13 new Pseudomonas species that remain to be formally classified. This work pinpoints the importance of correct taxonomic assignment and phylogenetic classification in order to perform integrative studies linking genetic diversity, lifestyle, and metabolic potential of Pseudomonas spp.
Complete Genome Resource of Pseudomonas coronafaciens X-1 Causing Halo Blight Disease in Oats.
Kim YC · Mol Plant Microbe Interact (2020)
· DOI: 10.1094/MPMI-05-20-0108-A
Pseudomonas coronafaciens X-1 was isolated from halo blight lesions on oat leaves in Korea. Currently, no genome resource on the oat halo blight pathogen is available. Here, the complete genome sequence of this strain, containing a circular chromosome and one circular megaplasmid is reported. This is the first genome sequence of the oat halo blight pathogen and will contribute to our understanding of the pathogenicity and ecological aspects of the halo blight pathogen and the interactions between P. coronafaciens and oats.
Microsporidia MB is found predominantly associated with Anopheles gambiae s.s and Anopheles coluzzii in Ghana.
Akorli J, Akorli EA, Tetteh SNA, Amlalo GK, Opoku M, Pwalia R, Adimazoya M, Atibilla D, Pi-Bansa S, Chabi J, Dadzie SK · Sci Rep (2021)
· DOI: 10.1038/s41598-021-98268-2
A vertically transmitted microsporidian, Microsporidia MB, with the ability to disrupt Plasmodium development was reported in Anopheles arabiensis from Kenya, East Africa. To demonstrate its range of incidence, archived DNA samples from 7575 Anopheles mosquitoes collected from Ghana were screened. MB prevalence was observed at 1.8%. An. gambiae s.s constituted 87% of positive mosquitoes while the remaining were from An. coluzzii. Both sibling species had similar positivity rates (24% and 19%; p = 0.42) despite the significantly higher number of An. gambiae s.s analysed (An. gambiae s.s = 487; An. coluzzii = 94; p = 0.0005). The microsporidian was also more prevalent in emerged adults from field-collected larvae than field-caught adults (p < 0.0001) suggestive of an efficient vertical transmission and/or horizontal transfer among larvae. This is the first report of Microsporidia MB in Anopheles mosquitoes in West Africa. It indicates possible widespread among malaria vector species and warrants investigations into the symbiont's diversity across sub-Saharan Africa.
Fungal biofilm-associated infections in immunocompromised African populations: A narrative review of Candidozyma auris emergence, antifungal resistance mechanisms, and laboratory detection algorithms.
Ukolobi O, Jacob JN, Akpo MO, Edo GI, Agbo JJ, Orogu JO, Yousif E, Jikah AN, Akpoghelie PO, Oghroro EEA, Essaghah AEA, Ahmed DS, Makia RS, Umar H, Alamiery AA, Fuwape IA · Diagn Microbiol Infect Dis (2026)
Nigeria · DOI: 10.1016/j.diagmicrobio.2026.117711
Candidozyma auris the abbreviation C. auris is retained throughout has become one of the most concerning hospital-acquired fungal infections over the past decade, colonizing the environment and skin for extended periods, exhibiting multidrug resistance, and forming biofilms that are resistant to both the host immune response and antifungal treatments. Sub-Saharan and North African medical institutions have a unique set of risks: a significant HIV-positive population, widespread malnutrition, high rates of tuberculosis co-infection, the appearance of critical care units, and diagnostic laboratories that often lack the tools to accurately identify emerging yeast species. This paper aims to analyze the current understanding of the emergence and prevalence of C. auris infections in African healthcare facilities, discuss the properties of biofilm formed by this yeast that facilitate its persistence and resistance to treatment, examine the features of immunosuppressed African patients who are at the highest risk of C. auris colonization and infection, and identify the available laboratory tests that can be used to diagnose this fungus in African hospitals. A narrative review has been performed to gather the evidence on the emergence of C. auris in African healthcare facilities and describe the general trends in its clinical presentation. The data were retrieved from reports and research articles published in peer-reviewed journals, utilizing resources such as national and multinational surveillance records, World Health Organization documents, and scientific publications from regional reference labs that investigate the clinical characteristics and treatment of C. auris infections and report on the local epidemiology of this yeast. Four principal findings emerge. First, documented African activity is concentrated in South Africa, Kenya, Nigeria and Egypt and is dominated by clade III and clade I, but the apparent continental increase conflates genuine transmission with rapidly improving detection capacity and should not be read as an incidence estimate. Second, fluconazole resistance is consistently high across African series (of the order of 85-90%), amphotericin B resistance is elevated relative to global pooled estimates (approximately 15-35%, highest in the clade III-dominated South African series), whereas echinocandin resistance remains below 5% but is no longer negligible. Third, biofilm growth confers a reversible, largely non-genetic tolerance matrix-mediated drug sequestration, biofilm-induced efflux upregulation and persister-cell dormancy that raises effective inhibitory concentrations by one to more than two orders of magnitude above planktonic values, so routine susceptibility reports systematically understate the drug exposure required in device-associated infection. Fourth, the dominant diagnostic constraint across the continent is not the absence of technology as such but systematic misidentification by the conventional biochemical panels that remain the mainstay of African yeast identification; this is addressable through a tiered algorithm anchored on a low threshold of suspicion rather than on universal access to mass spectrometry or sequencing. We conclude that C. auris preparedness in Africa is best pursued not as a vertical, pathogen-specific programme but as an explicit extension of the antimicrobial resistance surveillance, laboratory strengthening and infection prevention frameworks already under construction across the region, with tiered diagnostics, antifungal stewardship, biofilm-aware clinical management and the systematic evaluation of natural product-derived adjunctive agents as the immediate priorities.
Long-read sequencing of FLG identifies extensive copy number variation in exon 3 and detects rare loss-of-function variants.
Grentzinger V, Artesi M, Palmeira L, Renotte N, Cambisano N, Dideberg V, Helou L, Charloteaux B, Dezfoulian B, Absil G, Pêtre J, Sabatiello M, Meunier C, McLean WHI, Sandilands A, McAleer MA, Irvine AD, Uwineza A, Uwajeni AA, Olivier S, Durkin K, Bours V · JID Innov (2026)
Rwanda · DOI: 10.1016/j.xjidi.2026.100522
Loss-of-function (LOF) variants of the FLG gene are risk factors for atopic dermatitis. However, owing to the repetitive nature of exon 3, these variants are difficult to characterize. We sought to determine whether the use of long-read technologies would enable better characterization of the FLG gene and improve the detection of LOF variants. We sequenced a diverse clinical cohort of 192 samples collected in Belgium, Ireland, and Rwanda using long-read sequencing as well as publicly available data. We identified both common and rare LOF variants linked to atopic dermatitis in our clinical cohort, a number of compound heterozygotes, as well as 1 previously undescribed LOF variant. We also observed 20 previously undescribed FLG alleles, which varied in length by up to 13 kb. These were mostly found in samples of sub-Saharan origin and appear to be products of nonallelic homologous recombination. Despite the use of a long-read-based approach, we did not detect any FLG LOF variants in our African cohort, highlighting differences in FLG LOF burden and atopic dermatitis genetic risk between populations. Our approach has the potential to be a useful tool to identify FLG variants contributing to atopic dermatitis in various human populations.
Association mapping and molecular marker development for cassava brown streak disease resistance.
Sánchez-Sarria CE, Sheat S, Winter S, Kanju E, Zhang X, Morante N, Bolaños CA, Gómez-Martínez LA, Bohorquez-Chaux A, Mushi E, Mrema E, Salum K, Yang T, Wei T, Newby J, Gimode W · Front Plant Sci (2026)
Tanzania · DOI: 10.3389/fpls.2026.1977387
Cassava brown streak disease (CBSD) - caused by Cassava brown streak virus (CBSV) and Ugandan cassava brown streak virus (UCBSV) - severely threatens cassava production and food security in sub-Saharan Africa. Breeding for resistance is the most sustainable control strategy, but it requires reliable resistance sources and a clear understanding of the underlying genetic mechanisms.
In this study, we utilized resistance introduced from Latin American cassava germplasm and mapped the genetic basis of CBSD resistance relevant to African environments. Whole-genome sequencing (WGS) was applied to a segregating population consisting of 426 F1 progeny derived from crosses with CBSD-resistant lines and genome-wide association studies (GWAS) conducted to dissect the genetic basis of resistance.
A major QTL on chromosome 11 was consistently and significantly associated with CBSD resistance across multiple GWAS models tested and marker types (SNPs and indels), explaining up to 34.89% of the phenotypic variation. Three Kompetitive Allele Specific PCR (KASP) markers were developed and validated from the associated SNPs. All three markers successfully differentiated between known resistant and susceptible parental lines and the mapping population, and one remained significantly associated with resistance in a broader validation population. Interestingly, the same resistance region was previously reported in genetic mapping of East African germplasm, highlighting the central role of this locus across diverse genetic backgrounds. Developing these markers targeting the major chromosome 11 QTL provides a practical molecular tool to accelerate marker-assisted selection and facilitate the development of resistant cassava varieties, ultimately enhancing food security and supporting farmer livelihoods in regions affected by CBSD in Africa.
Rare coding variation implicates thirteen genes in bipolar disorder across 232,536 individuals from global populations.
Liao C, Ye R, Sealock JM, Boltz T, Ivankovic F, Finucane H, Howrigan D, Liu YC, Satterstrom FK, Hassan A, Alemayehu M, Gichuru S, Mwende RM, Newton CRJC, Koen N, Zingela Z, Diaz-Zuluaga AM, Ramirez-Diaz AM, Reus VI, Teshiba T, Palotie A, Hämäläinen E, Pietiläinen O, Lind PA, Siskind DJ, Hickie IB, Morales-Cedillo P, Jiménez-Pavón J, Sanabrais-Jiménez MA, Sotelo-Ramírez CE, Hahn E, Nguyen VP, Karlson E, Chang CE, Chen HC, Alda M, Landén M, Smoller JW, Craddock N, Vawter MP, Curtis D, McQuillin A, Kahn RS, Ophoff RA, Vreeker A, Hultman C, Sullivan PF, Talkowski ME, Blackwood DH, McIntosh A, Pulver AE, Cohen B, Adolfsson R, Reif A, Goes F, Yolken R, Corvin AP, Morris DW, BIPEX Collection Scientists, Cerrato F, Chapman SB, Cusick C, Guo Z, Olivares AM, Rouleau GA, Viswanath B, Kuo PH, Nguyen VT, Ta TMT, Camarena B, Pato CN, Pato MT, Medland SE, Freimer N, Loohuis LO, Lopez-Jaramillo C, Stroud R 2nd, Atwoli L, Dickens A, Koenen KC, Kariuki SM, Teferra S, Stein DJ, Ayub M, Knowles JA, Daly MJ, Huang H, Neale BM · medRxiv (2026)
Uganda · DOI: 10.64898/2026.09.30.26364416
Bipolar disorder (BD) is highly heritable, yet the contribution of rare coding variation remains incompletely characterized. We analyzed sequencing data from 64,435 individuals with BD and 168,101 controls spanning multiple ancestries and 22 countries, representing the largest and most global sequencing resource with a 6.7-fold increase in effective sample size over the previous study iteration. We observe enrichment of protein-truncating and damaging missense variants in constrained genes and curated neuropsychiatric gene sets, with no enrichment of synonymous variation. These enrichment signals were consistent across ancestry groups, suggesting that genetic risk factors for BD are consistent worldwide. Gene-level analyses identified 13 exome-wide significant genes and an additional 20 genes at FDR <0.05. These genes showed convergence with common and rare variant risk across other neuropsychiatric disorders. Expression analyses also showed preferential brain expression and increased developmental expression during early childhood. Modelling 3D protein structures further highlighted clustering of ultra-rare missense variants at a predicted interaction interfaces in two Bonferroni-significant genes, DOP1A and ATP9A; a potential mechanism linking membrane trafficking to BD risk. Together, these results implicate a constellation of rare variants that map onto neuronal biology and demonstrate that diverse global populations converge on shared genetic signals underlying BD risk.